Ugo Cavallari

Ugo Cavallari

Auto-generated profile, based on publicly available information

Ugo Cavallari

Servizio di Genetica, Azienda Istituti Ospitalieri, Cremona, Italy

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2008 in Lipids
Verified
Journal Article
Closed access
PDF file
Giovanni MalerbaGiovanni Malerba
Giovanni Malerba
LSLinda Schaeffer
Linda Schaeffer
LXLuciano Xumerle
Luciano Xumerle
NKNorman Klopp
Norman Klopp
ETElisabetta Trabetti
Elisabetta Trabetti
TIThomas Illig
Thomas Illig

1 January 2005 in Thrombosis Research
Verified
Journal Article
Closed access
Dominick Joseph AngiolilloDominick Joseph Angiolillo
Dominick Joseph Angiolillo
AFAntonio Fernandez-Ortiz
Antonio Fernandez-Ortiz
EBEsther Bernardo
Esther Bernardo
CRCelia Ramírez
Celia Ramírez
UCUgo Cavallari
Ugo Cavallari
CMCarlos Macaya
Carlos Macaya

5 September 2007 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
UCUgo Cavallari
Ugo Cavallari
ETElisabetta Trabetti
Elisabetta Trabetti
Giovanni MalerbaGiovanni Malerba
Giovanni Malerba
MBMichele Biscuola
Michele Biscuola
DGDomenico Girelli
Domenico Girelli
PPPier Franco Pignatti
Pier Franco Pignatti
Background: The platelet P2Y12 receptor plays a key role in platelet activation. The H2 haplotype of the P2Y12 receptor gene (P2RY12) has been found to be associated with maximal aggregation response to adenosine diphosphate (ADP) and with increased risk for peripheral arterial disease. No data are available on its association with coronary artery disease (CAD). Methods: The H2 haplotype of the P2RY12 was determined in 1378 unrelated patients of both sexes selected according to the presence of significant coronary artery disease (CAD group) or having normal coronary angiogram at cardiac catheterization (CAD-free group). Significant coronary artery disease was angiographically determined, and was defined as a greater than 50% visually estimated luminal diameter stenosis in at least one major epicardial coronary artery. Results: In the studied population 71.9% had CAD (n = 991) and 28.1% had normal coronary angiogram (n = 387). H2 haplotype carriers were more frequent in the CAD group (p = 0.03, OR = 1.36, 95%CI = 1.02–1.82). The H2 haplotype was significantly associated with CAD in non-smokers (p = 0.007, OR = 1.83 95%CI = 1.17–2.87), but not in smokers. The association remained significant after adjustment for other covariates (age, triglycerides, HDL, hypertension, diabetes) by multivariate logistic regression (p = 0.004, OR = 2.32 95%CI = 1.30–4.15). Conclusion: Gene sequence variations of the P2Y12 receptor gene are associated with the presence of significant CAD, particularly in non-smoking individuals.

15 October 2005 in The American Journal of Cardiology
Verified
Journal Article
Closed access
Dominick Joseph AngiolilloDominick Joseph Angiolillo
Dominick Joseph Angiolillo
AFAntonio Fernandez-Ortiz
Antonio Fernandez-Ortiz
EBEsther Bernardo
Esther Bernardo
CRCelia Ramírez
Celia Ramírez
UCUgo Cavallari
Ugo Cavallari
CMCarlos Macaya
Carlos Macaya

16 May 2007 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
DGDomenico Girelli
Domenico Girelli
NMNicola Martinelli
Nicola Martinelli
ETElisabetta Trabetti
Elisabetta Trabetti
OOOliviero Olivieri
Oliviero Olivieri
UCUgo Cavallari
Ugo Cavallari
RCRoberto Corrocher
Roberto Corrocher

26 October 2005 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
ETElisabetta Trabetti
Elisabetta Trabetti
MBMichele Biscuola
Michele Biscuola
UCUgo Cavallari
Ugo Cavallari
Giovanni MalerbaGiovanni Malerba
Giovanni Malerba
DGDomenico Girelli
Domenico Girelli
PPPier Franco Pignatti
Pier Franco Pignatti
The human oxidised low-density lipoprotein receptor 1 (OLR1) gene is a functional candidate for atherosclerosis. An association of the OLR1 gene with acute myocardial infarction (AMI) or coronary artery disease (CAD) has recently been reported. In the present study a total of 677 Italian subjects, 327 CAD-free, 350 CAD, of which 190 with AMI and 160 AMI-free, was genotyped for the following four OLR1 single nucleotide polymorphisms: exon 4 K167N, IVS4 –73C>T, IVS4 –14A>G, and 3′UTR 188 C>T. No statistically significant difference was observed in allele or genotype distribution of the exon 4, intron 4, or 3′UTR SNPs in CAD patients compared to CAD-free subjects, or within CAD, in AMI patients compared to AMI-free patients. A correlation was found between the K167N G/G genotype and the increased number of obstructed vessels. Even if the OLR1 genotype frequency distribution data in CAD or AMI subjects here reported do not fully confirm the positive results of some other association studies, an association with a marker of CAD severity was observed.